ABVC BIOPHARMA, INC. — Director's Dealing 2021

Nov 15, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABVC BIOPHARMA, INC. (ABVC)
CIK: 0001173313
Period of Report: 2021-08-02

Reporting Person: Jiang Eugene (Director, Chairman of the Board & CBO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	732716	Indirect

Footnotes

F1: Mr. Jiang holds 701,989 shares of the Company's common stock through his ownership in AsianGene, 5,352 shares of the Company's common stock through his ownership in BioFirst Corporation, 202 shares of the Company's common stock through his ownership in Rgene Corporation, and the rest of 25,173 shares through direct ownership. BioFirst and Rgene Corporation are related parties of the Company.